Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT1070250078) titled 'A Study to Confirm the Extent of Hemolysis and Renal Impairment in Radiofrequency Ablation for Atrial Fibrillation' on Sept. 30.
Study Type: Observational
Study Design:
treatment purpose
Primary Sponsor: Okamatsu Hideharu
Condition:
Atrial fibrillation
Atrial fibrillation
D001281
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 06/08/2025
Target Sample Size: 30
To know more, visit https://jrct.mhlw.go.jp/latest-detail/jRCT1070250078
Published by HT Digital Content Services with permission from Health Daily Digest....